Diabetes In India

China study claims stem cell therapy reversed type 2 diabetes in patient

Researchers report the first successful reversal of type 2 diabetes using stem cells, restoring natural insulin production and offering hope beyond lifelong insulin dependence

Ozempic and other weight-loss drugs: Cost, risks, who really needs them

As Ozempic and other GLP-1 drugs gain popularity, experts explain who qualifies, the real health benefits, potential risks, side effects, and why supervision is critical

Doctors flag risks of relying on HbA1c for diabetes diagnosis in India

Doctors warn that heavy reliance on HbA1c for diabetes diagnosis in India may lead to under- or over-diagnosis due to high anaemia and kidney disease burden, urging multiparametric testing

Why HbA1c, India's most trusted diabetes test, may be getting it wrong

A Lancet Regional Health-Southeast Asia study warns that HbA1c, the gold-standard diabetes test, can misdiagnose or delay diabetes in Indians due to widespread anaemia and blood disorders

Lupin signs licensing pact with Galenicum Health for injectable Semaglutide

Drug maker Lupin on Wednesday said its subsidiary, Lupin Atlantis Holdings SA (LAHSA), has inked a licence and supply agreement with Galenicum Health for diabetes and weight management medication. Lupin Atlantis Holdings SA (LAHSA) has entered into a partnership with Galenicum for finished formulations of injectable Semaglutide, a GLP-1 receptor agonist. As per the agreement, Galenicum will oversee development, manufacturing, and supply, while Lupin will handle regulatory submissions, approvals, and the commercialisation and distribution of Semaglutide across 23 countries globally, including Canada, Europe, Southeast Asia, and Latin America, the Mumbai-based drug maker said in a statement. "Our partnership with Galenicum marks a strategic milestone in strengthening Lupin's Semaglutide portfolio. As diabetes continues to escalate globally and obesity emerges as a major global health priority, Semaglutide stands out as a critical therapy," said Fabrice Egros, President, Corporate ...

India's diabetes burden hits 90 million as lifestyle shifts reshape health

India now has 90 million adults living with diabetes, second only to China. The IDF Diabetes Atlas warns the burden will rise sharply with ageing, urbanisation and lifestyle change

National Youth Day 2026: Top health challenges India's young can't ignore

Changing lifestyles, nutritional gaps and untreated mental health issues are pushing chronic diseases into younger age groups across India

How type 2 diabetes physically alters the heart and drives failure

A new human heart study shows type 2 diabetes does not just raise cardiac risk but physically alters heart muscle, energy use and structure, helping explain why heart failure is so common in diabetes

Can diabetes be reversed? Experts explain what really works in long term

Beyond crash diets and fads, doctors say diabetes remission is driven by realistic lifestyle changes, early action and consistency, not extreme workouts or quick fixes

Ozempic in India: What it does and how it fits into a growing health crisis

From regulating appetite to improving blood sugar control, GLP-1 drugs like Ozempic are emerging as powerful metabolic tools at a time when India urgently needs better solutions

How long sitting spikes your blood sugar, even if you work out daily

Doctors warn that long, uninterrupted sitting may worsen blood sugar, raise inflammation and weaken diabetes management, particularly among desk-based professionals

Only 27% of Mumbaikars aware of sugar risks, 15.6% pre-diabetic: BMC

A civic survey in Mumbai has indicated that only 27 per cent of residents are aware of the harmful effects of excessive sugar consumption, while 15.6 per cent are in the pre-diabetic stage. The Brihanmumbai Municipal Corporation (BMC) has appealed to residents to reduce sugar consumption and read food labels carefully before consuming processed foods. BMC Commissioner and Administrator Bhushan Gagrani has appealed to citizens to participate in the 'Healthy Campus Initiative', launched on the occasion of World Diabetes Day on November 14, to encourage healthier dietary and lifestyle practices. According to the World Health Organisation's Global Burden of Disease Studies, one in three people worldwide suffers from non-communicable diseases (NCDs) such as diabetes and hypertension, a civic release said. The BMC screened 5,59,751 individuals for diabetes and hypertension across its health institutions from August 2022 to October 2025, it said. As per the release, a civic survey has ..

Datanomics: Over 6% of India's population is living with diabetes

World Diabetes Day spotlights India's 89.8 million cases, top testing states, and need for early diagnosis, prevention, and continuous care

Childhood high blood sugar is rising fast. Here's how to stop it early

Paediatric experts say childhood high blood sugar is driven more by lifestyle than genes, sharing early signs and simple daily habits families can use to prevent long-term glucose problems

Diabetes on the rise: World diabetes day 2025 pushes for early care

With diabetes impacting families across the globe, World Diabetes Day 2025 focuses on raising awareness, encouraging prevention and strengthening access to timely care.

What is glycaemic index and how it helps you make healthier food choices?

Ahead of World Diabetes Day 2025, experts say GI awareness supports better glucose control and smarter meal planning

Tired, hungry and gaining weight? Insulin resistance could be to blame

A growing number of Indian families are facing insulin resistance-a silent health issue that often leads to diabetes. Know the signs, risks and lifestyle changes that can help prevent it early

Ten diabetes-friendly grains to steady blood sugar and support weight loss

World Diabetes Day 2025: Experts say shifting from high-GI staples to low-GI grains can help steady blood sugar, curb cravings, improve satiety, and support weight control with simple grain rotation

PharmEasy report finds 1 in 2 Indians tested have high blood sugar

Half of India's HbA1c test results fall in the diabetic range, PharmEasy report finds, warning of a growing diabetes crisis driven by lifestyle, regional, and gender disparities

Nuvama retains 'Hold' on Cipla, raises target after Eli Lilly diabetes deal

Cipla- Eli Lilly deal: Tirzepatide is a prescription drug used for managing type 2 diabetes and aiding weight loss in adults who are obese or overweight.